“I would advise pregnant women to take in as little caffeine as possible and switch to decaf altogether if they can,” Foxe stated.
But he urged ladies to not go chilly turkey in the event that they will help it, as a result of caffeine withdrawal could cause a bunch of signs, together with complications, irritability, nausea and problem concentrating.
“We don’t know what withdrawal, irritability, stress and anxiety will do to a pregnancy,” Foxe stated. “Try to whittle away at your caffeine consumption before you get pregnant.”
The examine does have some limitations. Women have been requested to recall how a lot caffeine they consumed whereas pregnant, and reminiscence is not at all times 100% correct.
The findings have been just lately printed on-line within the journal Neuropharmacology.
Dr. Mark Klebanoff, principal investigator on the Center for Perinatal Research in Columbus, Ohio, stated many research have appeared on the results of caffeine on being pregnant outcomes, equivalent to threat of miscarriage. But much less is thought about how caffeine impacts children as they age.
“The new study adds to the literature, but it’s not enough to really implicate caffeine in any strong way,” stated Klebanoff, who was not concerned with the examine however reviewed the findings.
“Pregnant women can be reasonably reassured that consuming less than 200 milligrams per day of caffeine will not cause miscarriage or preterm birth,” he stated. But extra examine is required on the way it impacts baby growth, Klebanoff added.
“A typical cup at home has about 100 mg of caffeine, so women can limit themselves to two cups a day when pregnant,” he stated.
But they need to take into account that different sources of caffeine (equivalent to vitality drinks, energy bars and chocolate) must be thought-about as a part of the entire, Klebanoff stated.
The American College of Obstetricians and Gynecologists provides recommendation on espresso and caffeine during pregnancy.
SOURCES: John Foxe, PhD, director, Del Monte Institute for Neuroscience, University of Rochester, Rochester, N.Y.; Mark Klebanoff, MD, principal investigator, Center for Perinatal Research, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, Ohio; Neuropharmacology, Jan. 30, 2021, on-line